675 related articles for article (PubMed ID: 19996923)
1. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder.
Barth RN; Nam AJ; Stanwix MG; Kukuruga D; Drachenberg CI; Bluebond-Langner R; Hui-Chou H; Shipley ST; Bartlett ST; Rodriguez ED
Transplantation; 2009 Dec; 88(11):1242-50. PubMed ID: 19996923
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.
Majewski M; Korecka M; Joergensen J; Fields L; Kossev P; Schuler W; Shaw L; Wasik MA
Transplantation; 2003 May; 75(10):1710-7. PubMed ID: 12777861
[TBL] [Abstract][Full Text] [Related]
3. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
4. Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft survival.
Barth RN; Bluebond-Langner R; Nam A; Stanwix M; Shipley S; Bartlett ST; Rodriguez ED
Plast Reconstr Surg; 2009 Feb; 123(2):493-501. PubMed ID: 19182606
[TBL] [Abstract][Full Text] [Related]
5. Swine hemi-facial composite tissue allotransplantation: a model to study immune rejection.
Kuo YR; Shih HS; Lin CC; Huang CC; Yang JC; Wu WS; Goto S; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):268-73. PubMed ID: 18708190
[TBL] [Abstract][Full Text] [Related]
6. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
Yang H; Chen G; Kanai N; Shum J; Garcia B; Huang X; Min W; Luo Y; Dutartre P; Zhong R
Transplantation; 2003 Apr; 75(8):1166-71. PubMed ID: 12717197
[TBL] [Abstract][Full Text] [Related]
7. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
9. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
10. Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation.
Mundinger GS; Munivenkatappa R; Drachenberg CB; Ha JS; Vaca EE; Shipley ST; Papadimitriou JC; Bartlett ST; Rodriguez ED; Barth RN
Transplantation; 2013 May; 95(10):1204-10. PubMed ID: 23694932
[TBL] [Abstract][Full Text] [Related]
11. Generation of donor hematolymphoid cells after rat-limb composite grafting.
Ajiki T; Takahashi M; Inoue S; Sakuma Y; Oyama S; Kaneko T; Hakamata Y; Murakami T; Kume A; Kariya Y; Hoshino Y; Kobayashi E
Transplantation; 2003 Mar; 75(5):631-6. PubMed ID: 12640301
[TBL] [Abstract][Full Text] [Related]
12. SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates.
Maki T; Carville A; Stillman IE; Sato K; Kodaka T; Minamimura K; Ogawa N; Kanamoto A; Gottschalk R; Monaco AP; Marr-Belvin A; Westmoreland SV; Sehgal P
Transplantation; 2008 Mar; 85(6):893-902. PubMed ID: 18360273
[TBL] [Abstract][Full Text] [Related]
13. A heterotopic primate model for facial composite tissue transplantation.
Silverman RP; Banks ND; Detolla LJ; Shipley ST; Panda A; Sanchez RA; Azimzadeh AM; Pierson RN; Wang D; Rodriguez ED; Holton LH; Bartlett ST
Ann Plast Surg; 2008 Feb; 60(2):209-16. PubMed ID: 18216518
[TBL] [Abstract][Full Text] [Related]
14. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
[TBL] [Abstract][Full Text] [Related]
15. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
17. Impact of donor bone marrow on survival of composite tissue allografts.
Siemionow M; Nasir S
Ann Plast Surg; 2008 Apr; 60(4):455-62. PubMed ID: 18362579
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia.
DiGiuseppe JA; Bastacky SI; Shirey RS; Silberman MA; Hutchins GM; Ness PM
Arch Pathol Lab Med; 1996 Mar; 120(3):282-5. PubMed ID: 8629906
[TBL] [Abstract][Full Text] [Related]
19. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer.
Muramatsu K; Valenzuela RG; Bishop AT
J Orthop Res; 2003 Nov; 21(6):1056-62. PubMed ID: 14554219
[TBL] [Abstract][Full Text] [Related]
20. Development of lymphoproliferative disease after liver transplantation.
Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
